Kronox Lab Sciences Analyst Review May 2026

This Kronox Lab Sciences analyst review for May 2026 covers all critical data investors need for KRONOX at Rs 136.82. Kronox Lab Sciences is a high-purity solvent manufacturer. This Kronox Lab Sciences analyst review analyses technical levels, business fundamentals, valuation, and key risks for KRONOX through FY27.

Click Here – Get Free Investment Predictions

Kronox Lab Sciences Analyst Review: Company Snapshot May 2026

Kronox Lab Sciences produces high-purity HPLC and GC grade solvents for pharmaceutical quality control, research, and industrial applications. The table below summarises key metrics for this Kronox Lab Sciences analyst review.

Parameter	Value
NSE Ticker	KRONOX
Sector	Specialty Chemicals – High Purity Solvents
CMP (May 2026)	Rs 136.82
52 Week High	Rs 164.18
52 Week Low	Rs 109.46
Market Cap	Rs 1200 Crore
Trailing P/E	35x
Analyst Consensus Target	Rs 171.02
Bull Case Target	Rs 212.07
Bear Case Target	Rs 116.30

Analyst Insight: Kronox Lab Sciences Analyst Review for FY27

Associate Director Kunal Singla suggests watching Kronox Lab Sciences closely in May 2026. At Rs 136.82, Kunal Singla flags Specialty Chemicals – High Purity Solvents sector dynamics as the key driver for KRONOX’s price action. Support is near Rs 111.65 and resistance near Rs 145.03. Kunal Singla’s perspective in this Kronox Lab Sciences analyst review is not a buy recommendation.

Technical Analysis in This Kronox Lab Sciences Analyst Review

This Kronox Lab Sciences analyst review places KRONOX at Rs 136.82 within its 52-week band of Rs 109.46 to Rs 164.18. The 14-day RSI, MACD signal, and volume profile are key technical inputs when evaluating KRONOX.

The Kronox Lab Sciences analyst review identifies support in the Rs 111.65 to Rs 129.98 range and resistance in the Rs 145.03 to Rs 153.92 zone. A sustained close above Rs 145.03 could signal momentum toward the analyst consensus target of Rs 171.02.

Screen the best stocks on the Univest Screener.

Support and Resistance in This Kronox Lab Sciences Analyst Review

• Support Zone: Rs 111.65 to Rs 129.98 – this Kronox Lab Sciences analyst review identifies this as a potential accumulation signal for KRONOX.
• Resistance Zone: Rs 145.03 to Rs 153.92 – the Kronox Lab Sciences analyst review flags a close above Rs 145.03 as a positive signal for KRONOX.
• Consensus Target: Rs 171.02 is the base-case target in this Kronox Lab Sciences analyst review.

Business Segments in This Kronox Lab Sciences Analyst Review

High-Purity HPLC and GC Solvents

This primary segment drives revenue and margin for Kronox Lab Sciences, supporting the earnings trajectory toward Rs 171.02 in this Kronox Lab Sciences analyst review.

Analytical Reagent Chemicals

This segment adds meaningful scale to Kronox Lab Sciences’s model and is a key EPS contributor through FY27 as identified in this Kronox Lab Sciences analyst review.

Pharma QC and Research Chemicals

This growth frontier is a potential re-rating catalyst for KRONOX and a key element of this Kronox Lab Sciences analyst review.

Valuation: Kronox Lab Sciences Analyst Review Bull Bear Base Case

At Rs 136.82 and P/E of 35x, this Kronox Lab Sciences analyst review sets three scenarios: bull case Rs 212.07, base case Rs 171.02, and bear case Rs 116.30.

Scenario	Target Price	Key Condition
Bull Case	Rs 212.07	Strong FY27 delivery and Specialty Chemicals – High Purity Solvents re-rating
Base Case	Rs 171.02	Moderate growth per analyst consensus in this Kronox Lab Sciences analyst review
Bear Case	Rs 116.30	Earnings miss or macro headwinds for KRONOX

FY27 Outlook in This Kronox Lab Sciences Analyst Review

This Kronox Lab Sciences analyst review for FY27 is constructive provided KRONOX delivers on earnings expectations. Q1 FY27 results will be the first checkpoint. Investors should monitor Specialty Chemicals – High Purity Solvents indicators, RBI policy, and FII flow trends.

Key Risks in This Kronox Lab Sciences Analyst Review

This Kronox Lab Sciences analyst review identifies four key risks for KRONOX: macro slowdown, input cost pressure, FII selling, and Q1 FY27 earnings disappointment.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Conclusion: Kronox Lab Sciences Analyst Review Verdict May 2026

This Kronox Lab Sciences analyst review concludes that KRONOX at Rs 136.82 presents a defined risk-reward with consensus target Rs 171.02. The 52-week range of Rs 109.46 to Rs 164.18 provides further context. Use this Kronox Lab Sciences analyst review as a research reference and consult a SEBI-registered advisor before investing in KRONOX.

FAQs: Kronox Lab Sciences Analyst Review 2026

What is the analyst target for Kronox Lab Sciences in 2026?

The Kronox Lab Sciences analyst review consensus target is Rs 171.02, bull case Rs 212.07, bear case Rs 116.30.

Is Kronox Lab Sciences a good buy at Rs 136.82?

At Rs 136.82 with PE 35x and target Rs 171.02, this Kronox Lab Sciences analyst review is constructive for 12-month investors. Consult a SEBI-registered advisor before acting on this Kronox Lab Sciences analyst review.

What is the 52-week high and low of Kronox Lab Sciences?

52-week high is Rs 164.18 and 52-week low is Rs 109.46. This Kronox Lab Sciences analyst review contextualises KRONOX at Rs 136.82 within this range.

What are the key risks for Kronox Lab Sciences?

Key risks in this Kronox Lab Sciences analyst review: macro slowdown, input cost pressure, FII selling, and competitive pressure in the Specialty Chemicals – High Purity Solvents sector.

Where can I track live data for Kronox Lab Sciences?

Track Kronox Lab Sciences’s live price on the Univest Screener to complement this Kronox Lab Sciences analyst review with real-time data.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.